Researchers at UC San Francisco have identified FTL1, a protein that significantly contributes to brain aging and cognitive decline. In experiments with aging mice, elevated levels of FTL1 correlated with weakened neuronal connections in the hippocampus and reduced memory performance. Conversely, reducing FTL1 levels in older mice led to a remarkable recovery, with restored neural connections and improved cognitive function, suggesting a potential therapeutic target for age-related cognitive impairments.

The study highlights the role of FTL1 in altering brain function by simplifying neuronal structures and slowing cellular metabolism in the hippocampus. When FTL1 levels were increased in younger mice, their brain morphology and behavior mirrored those of older mice, underscoring the protein’s influence on cognitive decline. Importantly, the research revealed that enhancing cellular metabolism could counteract the detrimental effects of FTL1, indicating a potential avenue for intervention.

The implications of these findings are significant for the field of aging biology. Targeting FTL1 may not only delay cognitive decline but could also reverse existing impairments, shifting the paradigm from merely managing symptoms of aging to actively restoring cognitive function. This opens new possibilities for developing therapies aimed at mitigating the effects of aging on the brain, potentially transforming approaches to age-related cognitive disorders.

Source: sciencedaily.com